Delta Health Care

Bucharest, Bucharest 014142

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Rheumatoid Arthritis

Studies at this site

• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling